Brand Name(s): Wellcovorin;
Citrovorum Factor; Folinic Acid
CAS nš: 1492-18-8
(loo koe VOR in)

About Leucovorin

This new site is dedicated exclusively to leucovorin, also known as folinic acid.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about leucovorin on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total leucovorin experience! 

Why is this medication prescribed?

Leucovorin is a drug that can be used either to protect healthy cells from chemotherapy or to enhance the anti-cancer effect of chemotherapy.

This medicine is most often used in cancer patients who are taking either methotrexate or fluorouracil chemotherapy. Methotrexate is used to treat a wide range of cancers including breast cancer, head and neck cancers, acute leukemias, and Burkitt's lymphoma. When leucovorin and methotrexate are used together, this therapy is often called leucovorin rescue because leucovorin rescues healthy cells from the toxic effects of methotrexate. 

Fluorouracil, on the other hand, is used in combination with leucovorin to treat colorectal cancer. In patients with colorectal cancer, however, leucovorin increases the anti-cancer effect of fluorouracil.

Leucovorin is also used to treat megaloblastic anemia, a blood disorder in which red blood cells become larger than normal, and to treat accidental overdoses of drugs like methotrexate.

See more Product Info

Latest News

Stop-and-Go Oxaliplatin Effective in Elderly Colon Cancer Patients

Elderly patients with metastatic colon cancer, those between 76 and 80 years of age, have response...

[more]

More cancer patients to be treated with Eloxatin(R) following Health Canada's approval of new indication

Health Canada has approved Eloxatin(R) (oxaliplatin for injection), in combination with infusional...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.